Advertisement

N-(Fluorenyl-9-methoxycarbonyl)amino Acid Amide Derivatives as a New Class of Anti-cancer Agents

  • Lajos Gera
  • Daniel C. Chan
  • Vitalija Simkeviciene
  • Paul A. Jr Bunn
  • John M. Stewart
Part of the Advances in Experimental Medicine and Biology book series (volume 611)

Keywords

Small Cell Lung Cancer Acid Amide Amide Derivative Amino Acid Amide Protected Amino Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Gera, L., Stewart, J.M., Whalley, E., Burkard, M. and Zuzack, J. Immunopharmacol. 33, 178–182 (1996).CrossRefGoogle Scholar
  2. 2.
    Gera, L., et al. In Flegel, M., Fridkin, M., Gilon, C. and Slaninova, J. (Eds.) Peptides 2004, Proceedings of the 3rd International and 28th Eur. Peptide Symp. International, Geneva, 2005, pp. 846–847.Google Scholar
  3. 3.
    Gera, L., et al. In Martinez J. and. Fehrentz, J.-A. (Eds.) Peptides 2000, Proceedings of the 26th Eur. Peptide Symp. Edk, Paris, 2001, pp. 637–638.Google Scholar
  4. 4.
    Birch, R.M., et al. Proc. Nat. Acad. Sci. USA. 88, 355–359 (1991).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Lajos Gera
    • 1
    • 3
  • Daniel C. Chan
    • 2
    • 3
  • Vitalija Simkeviciene
    • 1
  • Paul A. Jr Bunn
    • 2
    • 3
  • John M. Stewart
    • 1
    • 3
  1. 1.Department of Biochemistry and Molecular GeneticsUniversity of Colorado Health Sciences CenterDenver
  2. 2.Cancer CenterUniversity of Colorado Health Sciences CenterAuroraUSA
  3. 3.ApopLogic Pharmaceuticals LLCAuroraUSA

Personalised recommendations